[1]
S. F. Qasim, T. Ahsan, S. Ghaus, and P. Imran, “Efficacy and safety profile of Glucagon-Like Peptide-1 Receptor Agonist in obese Type-2 diabetes patients from a private institution in Karachi”, Pak J Med Sci, vol. 39, no. 4, Jun. 2023.